Lin X
Front Cell Dev Biol. 2021; 9:795883.
PMID: 34901036
PMC: 8656232.
DOI: 10.3389/fcell.2021.795883.
Cunningham S, Tanner D
Int J Environ Res Public Health. 2020; 17(16).
PMID: 32785196
PMC: 7460322.
DOI: 10.3390/ijerph17165795.
Nguyen H, Moir M, Nguyen T, Vu A, Luong L, Nguyen T
Patient Prefer Adherence. 2018; 12:1347-1354.
PMID: 30100711
PMC: 6067618.
DOI: 10.2147/PPA.S162892.
Ridyard C, Dawoud D, Tuersley L, Hughes D
Patient. 2016; 9(4):281-92.
PMID: 26792584
DOI: 10.1007/s40271-015-0160-x.
Akhrass F, Skinner N, Boswell K, Travis L
Am Health Drug Benefits. 2014; 3(2):117-22.
PMID: 25126313
PMC: 4106519.
Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes.
Profit L
Core Evid. 2012; 1(2):89-101.
PMID: 22500147
PMC: 3321660.
Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients' cognitive framework.
Peyrot M, Rubin R
Patient Prefer Adherence. 2011; 5:255-65.
PMID: 21792298
PMC: 3140308.
DOI: 10.2147/PPA.S18799.
Peer reviewed publications in 2005.
Ochsner J. 2011; 6(1):43-5.
PMID: 21765791
PMC: 3124947.
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design.
Strack T, Martinez L, Del Prato S, Blonde L, Goke B, Woo V
Diabetes Metab Syndr Obes. 2011; 2:1-10.
PMID: 21437114
PMC: 3048012.
Exploring patients' perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study.
Guimaraes C, Marra C, Gill S, Meneilly G, Simpson S, Godoy A
Patient Prefer Adherence. 2010; 4:171-9.
PMID: 20694179
PMC: 2915552.
DOI: 10.2147/ppa.s10178.
Inhaled insulin: overview of a novel route of insulin administration.
Mastrandrea L
Vasc Health Risk Manag. 2010; 6:47-58.
PMID: 20234779
PMC: 2835554.
DOI: 10.2147/vhrm.s6098.
Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes.
Tack C, Christov V, de Galan B, Derwahl K, Klausmann G, Pelikanova T
J Diabetes Sci Technol. 2009; 2(1):47-57.
PMID: 19885177
PMC: 2769695.
DOI: 10.1177/193229680800200108.
Psychological insulin resistance: patient beliefs and implications for diabetes management.
Brod M, Kongso J, Lessard S, Christensen T
Qual Life Res. 2008; 18(1):23-32.
PMID: 19039679
DOI: 10.1007/s11136-008-9419-1.
Inhaled insulin--what went wrong.
Mitri J, Pittas A
Nat Clin Pract Endocrinol Metab. 2008; 5(1):24-5.
PMID: 18981990
PMC: 4042087.
DOI: 10.1038/ncpendmet1007.
Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.
Chancellor J, Aballea S, Lawrence A, Sheldon R, Cure S, Plun-Favreau J
Pharmacoeconomics. 2008; 26(3):217-34.
PMID: 18282016
DOI: 10.2165/00019053-200826030-00005.
Inhaled insulin for controlling blood glucose in patients with diabetes.
Silverman B, Barnes C, Campaigne B, Muchmore D
Vasc Health Risk Manag. 2008; 3(6):947-58.
PMID: 18200813
PMC: 2350138.
Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
Martinez L, Consoli S, Monnier L, Simon D, Wong O, Yomtov B
Health Qual Life Outcomes. 2007; 5:53.
PMID: 17727695
PMC: 2042975.
DOI: 10.1186/1477-7525-5-53.
Inhaled human insulin (Exubera): clinical profile and patient considerations.
Barnett A, Bellary S
Vasc Health Risk Manag. 2007; 3(1):83-91.
PMID: 17583178
PMC: 1994047.
Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes.
Hollander P
MedGenMed. 2007; 9(1):45.
PMID: 17435648
PMC: 1925008.
Inhaled insulins.
Ghosh S, Collier A
Postgrad Med J. 2007; 83(977):178-81.
PMID: 17344572
PMC: 2599981.
DOI: 10.1136/pgmj.2006.053868.
